RESUMO
OBJECTIVE:To observe therapeutic efficacy and safety of Tripterygium tablets combined with Compound α-keto acid tablets in the treatment of diabetic nephropathy(DN)patients. METHODS:A total of 186 DN patients were randomly divided into control group(93 cases)and study group group(93 cases). Based on routine treatment,control group was given Tripterygium tablet 20 mg orally,3 times a day;study group was additionally given Compound α-keto acid tablet 3.78 g orally,3 times a day, on the basis of control group. Both groups were treated for consecutive 3 months. Clinical efficacies of 2 groups were observed, and the levels of renal function indexes (Scr,BUN,CysC,GFR,24 h urine protein),renal interstitial fibrosis indexes (Hcy, VEGF,HGF,TGF-β1) and oxidative stress indexes (T-AOC,SOD,AOPP,MDA),the occurrence of ADR were also observed before and after treatment. RESULTS:No patient withdrew from the experiment in 2 groups,and all completed the treatment. Total response rate of study group (91.39%) was significantly higher than that of control group (80.65%),with statistical significance (P<0.05). After treatment,the levels of Scr,BUN,CysC and 24 h urine protein,Hcy,VEGF,TGF-β1,AOPP and MDA in 2 groups were significantly lower than before,and the study group was significantly lower than the control group;the levels of GFR,HGF,T-AOC and SOD in 2 groups were significantly higher than before treatment,and the study group was significantly higher than the control group,with statistical significance(P<0.05). There was no statistical significance in the incidence of ADR between 2 groups(P>0.05). CONCLUSIONS:Tripterygium tablets combined with Compound α-keto acid tablets show significant therapeutic efficacy for DN patients but do not increase the occurrence of ADR.
RESUMO
Objective To study the effect of lithium chloride on the gap junction in the myocardium under chronic hypoxia.Methods Twenty-five C57BL/6J mice were randomly divided into normoxia group,hypoxia group,normoxic control group,hypoxia + saline group and hypoxia + lithium chloride group.Hypoxia group was treated with 10％ oxygen concentration for 4 weeks.Hypoxia + saline group and hypoxia + lithium chloride group were intraperitoneal injection of saline and lithium chloride.Electrophysiology and cardiac catheterization were used to assess arrhythmias,heart rate and ejection fraction.The expression of Cx43,phosphorylated glycogen synthase kinase 3β(p-GSK-3β) and glycogen synthase kinase 3β (GSK-3β) were detected by Western blot.Results Compared with the normoxia group,the hypoxia group had a faster heart rate [(448 ± 18) bpm vs.(401 ± 13) bpm,P＜0.05),and the ejection fraction was decreased [(56±5)％ vs.73±4)％,P＜0.05],arrhythmia score increased [(3.4±0.5)％ vs.(0.6±0.5)％,P＜0.05],Cx43 expression was decreased.Compared to hypoxia + normal saline group,the heart rate decreased[(412±11)bpm vs.(454±18)bpm,P＜0.05],ejection fraction increased[(69±3)％ vs.(55±4)％,P＜0.05],the score of arrhythmia decreased [(1.8±0.4) ％ vs.(3.0±0.7)％,P＜0.05] in hypoxia + lithium chloride group,the expression of Cx43 and the rate of p-GSK-3β to GSK-3β were increased.Conclusion During the chronic hypoxia,lithium chloride can sustain the gap junction through inhibition of GSK-3β signaling way,which can also reduce the rate of arrhythmia.